Literature DB >> 15076817

The effect of alcoholism treatment on medical care use.

Robert L Kane1, Melanie Wall, Sandra Potthoff, Kurt Stromberg, Yu Dai, Zachary J Meyer.   

Abstract

OBJECTIVE: The objective of this study was to assess changes in outpatient and inpatient medical care utilization associated with outpatient and inpatient treatment of alcohol abuse by comparing alcoholics who engaged in treatment to alcoholics who presented for, but did not engage in, treatment. RESEARCH
DESIGN: Claims and encounter data of 29,122 adults receiving benefits from both a behavioral managed care company and its parent medical care insurance company who had a diagnosis of alcoholism were analyzed. The nontreated alcoholics in this sample (n = 13,133) were used for comparison and to control for historical time trend in medical utilization across the study years 1993-1999. A longitudinal over-dispersed Poisson regression model was fit by the generalized estimating equation method to compare differences in medical utilization before and after outpatient and inpatient alcoholism treatment.
RESULTS: The pattern of medical utilization before and after alcoholism treatment appears basically symmetric. There is a gradual increase, which accelerates in the year before treatment and then falls off rapidly for the first year after treatment and then falls more gradually. Such a pattern does not suggest any net savings over time. The area under the curve before treatment is basically equivalent to that after treatment. Slopes of medical utilization for both treatment groups before 1 year before treatment were statistically similar to the control groups, but during 1 year before treatment, both treatment groups' outpatient utilization increased 1.25% and inpatient utilization increased 1.8% relative to the nontreated group. The slopes posttreatment showed differential effects over time of inpatient versus outpatient alcoholism treatment on inpatient and outpatient medical utilization.
CONCLUSIONS: Although a clear increase in medical utilization before treatment and a decrease in utilization after treatment was found, it is not clear if the change is linked to changes in the status of the individuals as they prepare to enter alcoholism treatment or if there is a real causal effect of the alcoholism treatment.

Entities:  

Mesh:

Year:  2004        PMID: 15076817     DOI: 10.1097/01.mlr.0000118865.63346.23

Source DB:  PubMed          Journal:  Med Care        ISSN: 0025-7079            Impact factor:   2.983


  6 in total

1.  Medical cost-offset following treatment referral for alcohol and other drug use disorders in a group model HMO.

Authors:  Michael R Polen; Donald K Freeborn; Frances L Lynch; John P Mullooly; Daniel M Dickinson
Journal:  J Behav Health Serv Res       Date:  2006-07       Impact factor: 1.505

2.  The effect of substance abuse treatment on Medicaid expenditures among general assistance welfare clients in Washington state.

Authors:  Thomas M Wickizer; Antoinette Krupski; Kenneth D Stark; David Mancuso; Kevin Campbell
Journal:  Milbank Q       Date:  2006       Impact factor: 4.911

3.  The effect of alcohol treatment on social costs of alcohol dependence: results from the COMBINE study.

Authors:  Gary A Zarkin; Jeremy W Bray; Arnie Aldridge; Michael Mills; Ron A Cisler; David Couper; James R McKay; Stephanie O'Malley
Journal:  Med Care       Date:  2010-05       Impact factor: 2.983

4.  Multiple indicator hidden Markov model with an application to medical utilization data.

Authors:  Melanie M Wall; Ran Li
Journal:  Stat Med       Date:  2009-01-30       Impact factor: 2.373

Review 5.  A literature review of cost-benefit analyses for the treatment of alcohol dependence.

Authors:  Svetlana Popova; Satya Mohapatra; Jayadeep Patra; Amy Duhig; Jürgen Rehm
Journal:  Int J Environ Res Public Health       Date:  2011-08-16       Impact factor: 3.390

Review 6.  A pharmaceutical industry perspective on the economics of treatments for alcohol and opioid use disorders.

Authors:  David R Gastfriend
Journal:  Ann N Y Acad Sci       Date:  2014-09-18       Impact factor: 5.691

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.